Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [615]
News [1043]
Articles [54]
Editorials [2]
Conferences [96]
elearning [5]
Toxicity of aromatase inhibitors may explain lack of overall survival improvement
Toxicity of aromatase inhibitors may explain lack of overall survival improvement
5 years of tamoxifen improves 15-year survival by about a third in women with most common type of breast cancer
5 years of tamoxifen improves 15-year survival by about a third in women with most common type of breast cancer
Breast density tied to specific types of breast cancer
Breast density tied to specific types of breast cancer
Hormone therapy may be hazardous for men with heart conditions
Hormone therapy may be hazardous for men with heart conditions
Pancreatic Cancer: Challenges and Hopes
Pancreatic Cancer: Challenges and Hopes
St Gallen recommends new approach to breast cancer classification
St Gallen recommends new approach to breast cancer classification
Some oestrogen-negative breast cancer patients may benefit from prostate cancer therapy
Some oestrogen-negative breast cancer patients may benefit from prostate cancer therapy
Genomic predictor of survival in invasive breast cancer
Genomic predictor of survival in invasive breast cancer
High impact radiopeptide therapy halts neuroendocrine cancer
High impact radiopeptide therapy halts neuroendocrine cancer
Adjuvant endocrine therapy plus zoledronic acid shows benefit in early stage breast cancer
Adjuvant endocrine therapy plus zoledronic acid shows benefit in early stage breast cancer

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation